Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade

Background: Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract (GIT) that represent approximately 1 to 2 percent of primary gastrointestinal (GI) cancers. Owing to their rarity, very little is known about their overall epidemiology, and the prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangolo, Ayrton, Fwelo, Pierre, Al-Qatish, Tha’er, Bukasa-Kakamba, John, Lee, Tiffany, Cayago, Akira G., Potiguara, Sarah, Nagesh, Vignesh K., Kawall, Jessica, Ahmed, Rashid, Asjad Abbas, Muhammad, Nursjamsi, Narissa, Lee, Stacy H., Meti, Shagi, Arana, Georgemar V., Joseph, Chrishanti A., Mohamed, Abdifitah, Alencar, Arthur, Hassan, Huzaifa G., Aryal, Pramanu, Javed, Aleena, Kalinin, Maksim, Lawal, Gbenga, Khalaf, Ibtihal Y., Mathew, Midhun, Karamthoti, Praveena, Gupta, Bhavna, Weissman, Simcha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536810/
https://www.ncbi.nlm.nih.gov/pubmed/37755158
http://dx.doi.org/10.3390/medsci11030054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536810/
https://www.ncbi.nlm.nih.gov/pubmed/37755158
http://dx.doi.org/10.3390/medsci11030054

Ejemplares similares